Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor

Viral Gastroenteritis Companies

ID: MRFR/HC/3027-HCR
200 Pages
Vikita Thakur
Last Updated: February 16, 2025
Viral gastroenteritis, often referred to as the stomach flu, is an inflammation of the stomach and intestines caused by a viral infection. There are various viruses that can lead to gastroenteritis, including norovirus, rotavirus, and adenovirus. While there are no specific companies solely dedicated to viral gastroenteritis treatment or prevention, there are pharmaceutical and biotechnology companies that may be involved in developing antiviral medications, vaccines, or other related products.
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Viral Gastroenteritis Market

Market Size

Forecast Period2025 - 2035
CAGR (2025 - 2035)4.24%
2024 Market Size$ 2.22 Billion
2025 Market Size$ 2.31 Billion
2035 Market Size$ 3.5 Billion

Key Players

GSK
Merck & Co.
Pfizer
Sanofi
Bristol-Myers Squibb
Johnson & Johnson
Opportunities
  • Rising Healthcare Expenditure
  • Growing Demand for Preventive Healthcare
  • Impact of Climate Change on Disease Patterns

Top Industry Leaders in the Viral Gastroenteritis Market

Viral Gastroenteritis Key Companies
ย 
Latest Viral Gastroenteritis Companies Update
ย 

BioPerfectus expands portfolio with rapid PCR Kits for Gastrointestinal Infectious Diseases The company launched 10 new kits offering a quicker and more accessible diagnostic solution, promoting accurate treatment decision-making

Co-Diagnostics receives FDA Emergency Use Authorization for its Rotavirus RT-PCR Assay novel test enables rapid and highly accurate detection of rotavirus, enabling faster diagnosis and targeted treatment for children, the most affected age group.

Takeda Pharmaceuticals strengthens presence in Japan with Vaxelis (rotavirus vaccine) The company's vaccine received expanded coverage under the national immunization program, potentially leading to a decline in rotavirus-related cases in Japan.

Abbott releases updated LumiraDx Rapid Rotavirus and Adenovirus Duo Test point-of-care test allows for quicker diagnosis at healthcare facilities, enabling immediate patient management and infection control measures.

List of Viral Gastroenteritis Key Companies in the Market

  • Valeant Pharmaceuticals International Inc. (U.S.)
  • Janssen Global Services
  • LLC U.S.)
  • Takeda Pharmaceutical (Japan)
  • Bayer AG (Germany)
  • Sanofi (France)
  • Allergan (Ireland)
  • GlaxoSmithKline (U.S.)
  • Abbott (U.S.)
  • AstraZeneca (U.K).